Schedule-dependent and -independent Antitumor Activity of Paclitaxel-based Combination Chemotherapy against M-109 Murine Lung Carcinoma in vivo

スポンサーリンク

概要

• 論文の詳細を見る
• 1998-12-30

著者

• Fujimoto Shuichi

  Division Of Chemotherapy Chiba Cancer Center Research Institute

• Chikazawa Hirotaka

  Kanagawa Laboratories Clinical Research & Product Development Division Bristol-myers Squibb K.k.

関連論文

• Rectal Absorption of [Bis (acetato) ammine dichloro (cyclohexylamine)platinum(IV)](BMS-182751), a New Anti-tumor Agent, in Rats
• Anti-tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts
• A COMPARISON OF A NEW NITROSOUREA DERIVATIVE, 1-(2-CHLOROETHYL)-3-ISOBUTYL-3-(β-MALTOSYL)-1-NITROSOUREA WITH VARIOUS ANTITUMOR AGENTS WITH RESPECT TO THERAPEUTIC RATIOS IN L1210 LEUKEMIA SYSTEMS
• Schedule-Dependent Antitumor Activity and Toxicity of Combinations of 5-Fluorouracil and Cisplatin/Carboplatin against L1210 Leukemia-Bearing Mice(Biopharmacy)
• Promising Antitumor Activity of a Novel Quinoline Derivative, TAS-103, against Fresh Clinical Specimens of Eight Types of Tumors Measured by Flow Cytometric DNA Analysis(Highlighted paper selected by Editor-in-chief,Biopharmacy)
• Schedule-dependent and -independent Antitumor Activity of Paclitaxel-based Combination Chemotherapy against M-109 Murine Lung Carcinoma in vivo
• ENHANCED ANTITUMOR ACTIVITY OF 5'-DEOXY-5-FLUOROURIDINE AGAINST LEWIS LUNG CARCINOMA IN AGED HYBRID (C57BL/6×DBA/2) F_1 MICE

スポンサーリンク